| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/18/2001 | EP1091762A1 Transgene expression in polarized cells |
| 04/18/2001 | EP1091759A2 Composition for the induction of apoptosis in target cells |
| 04/18/2001 | EP1091757A2 Alpha emitting constructs and uses thereof |
| 04/18/2001 | EP1091745A1 Treatment of hyperproliferative disorders |
| 04/18/2001 | EP1091741A1 Azepine derivatives having effects on serotonin related systems |
| 04/18/2001 | EP1091739A1 Method for inhibiting c-jun expression using jak-3 inhibitors |
| 04/18/2001 | EP1091738A1 BICYCLIC sPLA 2 INHIBITORS |
| 04/18/2001 | EP1091737A2 Calcium channel blockers |
| 04/18/2001 | EP1091736A1 Inhibitors of prenyl-protein transferase |
| 04/18/2001 | EP1091735A1 Application for utility patent for improved enriched platelet wound healant |
| 04/18/2001 | EP1091734A1 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa |
| 04/18/2001 | EP1091726A2 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis |
| 04/18/2001 | EP0797437B1 IMMUNOTHERAPEUTIC IMIDES/AMIDES AND THEIR USE FOR REDUCING LEVELS OF TNFalpha |
| 04/18/2001 | EP0731697B1 Ssi tyrphostins and pharmaceutical compositions |
| 04/18/2001 | EP0682663B1 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b]pyran-2-ones useful to treat retroviral infections |
| 04/18/2001 | EP0663832B1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis |
| 04/18/2001 | CN1292032A Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/18/2001 | CN1291994A New salt forms of (2E)-5-amino-5-methylhex-2-enoic acid N-methyl-N-((1R)-1-(N-methyl-N-((1R)-2-(methylcarbamoyl)-2-phenylethyl) carbamoyl)-2-(2-naphtyl) ethyl) amide |
| 04/18/2001 | CN1291993A Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes |
| 04/18/2001 | CN1291984A Glycine transport inhibitors |
| 04/18/2001 | CN1291981A Thiophene nitrone compounds |
| 04/18/2001 | CN1291980A thioether furan nitrone compounds |
| 04/18/2001 | CN1291978A Meta-azacyclic amino benzoic acid compound and derivatives thereof being integrin antagonists |
| 04/18/2001 | CN1291977A Amino anthracyclinone derivatives and their use in treatment of amyloidosis |
| 04/18/2001 | CN1291974A Cyclohexanediole derivatives |
| 04/18/2001 | CN1291892A Substituted oxoazaheterocyclyl factor Xa inhibitors |
| 04/18/2001 | CN1291889A Fluoxetine hydrochloride for decreasing hot flashes |
| 04/18/2001 | CN1291609A Method of preparing 5-lipoxidase inhibitor possessing different heterocyclic ring system |
| 04/18/2001 | CN1291480A Detoxicating tea for cleaning intestine |
| 04/18/2001 | CN1291475A Cell-protecting amifostine and its preparing process |
| 04/18/2001 | CN1064676C Ortho-substituted benzoyl guanidine, its preparation, use and medicines containing it |
| 04/18/2001 | CN1064674C Alkoxyaryl compounds, their process of preparation and pharmaceutical compositions which contain them |
| 04/18/2001 | CN1064550C Medicine for treating premenstrual tension |
| 04/18/2001 | CN1064539C Internal heat-reducing cooling tea |
| 04/17/2001 | US6218538 Antagonists of n-type neuronal calcium channels useful in the treatment of cerebrovascular ischaemia and pain. |
| 04/17/2001 | US6218537 Process for making pyridyl and pyrimidine substituted imidazole compounds |
| 04/17/2001 | US6218429 Tricyclic compounds, their production and use |
| 04/17/2001 | US6218426 For therapy of mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated |
| 04/17/2001 | US6218425 Useful in the treatment of estrogen-related disorders such as osteoporosis, hyperlipidemia, estrogen-related breast cancer, uterine fibrosis, endometriosis, and restenosis |
| 04/17/2001 | US6218423 Administering pyrrolidine derivative for therapy of nerve-related vision disorder, improving vision, treating memory impairment, or enhancing memory performance in animal |
| 04/17/2001 | US6218419 Aminoiminoquinone and aminoquinone alkaloid compounds and methods of use |
| 04/17/2001 | US6218418 Therapy of cell proliferative disorders associated with an altered cell dependent kinase activity by administering amino pyrazole derivative to mammal |
| 04/17/2001 | US6218417 Ace-inhibitor nitric salts |
| 04/17/2001 | US6218415 Therapy of bone reabsorption by osteoclasts, tumor growth and tumor metastasis, inflammation, cardiovascular disease, nephropathies and retinopathies |
| 04/17/2001 | US6218414 Administering an effective amount of an angiotensin ii antagonist and a benzofuran derivative with antiarrhythmic activity for therapy of cardiovascular complaints |
| 04/17/2001 | US6218409 Administering insulin sensitivity enhancer in combination with an aldose reductase inhibitor for reducing side effects of diabetic drugs |
| 04/17/2001 | US6218403 Antithrombotic and antiatherogenic pharmaceutical composition including a thienopyridine derivative and an HMG-CoA-reductase inhibitor |
| 04/17/2001 | US6218402 Antagonizing the serotonin 5ht3 receptor with a pyrrolo quinoline derivative |
| 04/17/2001 | US6218396 Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia |
| 04/17/2001 | US6218394 4-Aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophene-methyl) piperazines |
| 04/17/2001 | US6218390 Morpholinone and morpholine derivatives and uses thereof |
| 04/17/2001 | US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices |
| 04/17/2001 | US6218385 1,2,4,5-Tetrahydro-benzo[D]azepin derivatives |
| 04/17/2001 | US6218381 Fused imidazole derivatives as multidrug resistance modulators |
| 04/17/2001 | US6218377 Methods for the administration of amifostine and related compounds |
| 04/17/2001 | US6218370 Useful for cell transfection |
| 04/17/2001 | US6218369 Administering flavanolignane selected from silymarin, silybin, silidianin, silicristin, dehydrosilybin, phospholipid complex of one of these flavanolignanes, and mixtures, in combination with antitumor agent |
| 04/17/2001 | US6218366 Method for raising the hypoxic threshold |
| 04/17/2001 | US6218359 Treating autoimmune, arthritic, tumor diseases |
| 04/17/2001 | US6218179 Nucleotide sequences coding human metallothionein regulatory sequences; for reducing ischemic injury to a cell exposed to hypoxic conditions |
| 04/17/2001 | US6218159 Amino acid sequence; bacteriostats; bactericides; antibiotics; diagnosis of infections; drug screening |
| 04/17/2001 | US6218136 Methods of the identification of pharmaceutically active compounds |
| 04/17/2001 | US6217883 Immunology response |
| 04/17/2001 | US6217875 Inhibitors of lipoxygenase |
| 04/17/2001 | US6217866 Antitumor agents mixture |
| 04/17/2001 | US6216707 Use of at least an Irvingia gabonensis extract in a cosmetic and/or pharmaceutical product |
| 04/17/2001 | CA2220018C Crystalline [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 04/17/2001 | CA2196054C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 04/17/2001 | CA2195863C Therapeutic drug for endotoxin blood symptom and multi-organ failure induced thereby |
| 04/17/2001 | CA2185192C Novel substituted 2,2,-dimethyl-w-phenoxyalcanoic acids and esters; process for preparing the same and pharmaceutical compositions containing them |
| 04/17/2001 | CA2158457C Naphthalene derivatives |
| 04/17/2001 | CA2157003C Hormone replacement therapy |
| 04/17/2001 | CA2156742C Phosphonomethyldipeptides |
| 04/17/2001 | CA2110670C Spiro piperidines and homologs which promote release of growth hormone |
| 04/17/2001 | CA2027765C Mevinic acid derivatives |
| 04/12/2001 | WO2001025793A2 Diagnosis of coeliac disease using a gliadin epitope |
| 04/12/2001 | WO2001025486A1 Methods for identifying rna binding compounds |
| 04/12/2001 | WO2001025465A1 Adeno-associated viruses and uses thereof |
| 04/12/2001 | WO2001025450A1 Use of soluble costimulatory factor for tumor immuno-gene therapy |
| 04/12/2001 | WO2001025446A1 Dna encoding prost 07 polypeptide |
| 04/12/2001 | WO2001025442A1 Dna polymerase lambda and uses thereof |
| 04/12/2001 | WO2001025441A2 Tumour-specific vector for gene therapy |
| 04/12/2001 | WO2001025437A2 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | WO2001025436A2 Endozepine-like polypeptides and polynucleotides encoding same |
| 04/12/2001 | WO2001025410A2 DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR |
| 04/12/2001 | WO2001025397A2 Compositions and methods for tumor-targeted delivery of effector molecules |
| 04/12/2001 | WO2001025269A2 Human g-protein coupled receptor |
| 04/12/2001 | WO2001025266A1 Uroguanylin as an intestinal cancer inhibiting agent |
| 04/12/2001 | WO2001025258A1 Human inwardly rectifying potassium channel subunit |
| 04/12/2001 | WO2001025248A2 Design of high affinity rnase h recruiting oligonucleotide |
| 04/12/2001 | WO2001025240A1 HEXAHYDROFURO'2,3-B!FURAN-3-YL-N- {3'(1,3-BENZODIOXOL -5- YLSULFONYL) (ISOBUTYL) AMINO! -1-BENZYL-2-HYDROXYPROPYL} CARBAMATE AS RETROVIRAL PROTEASE INHIBITOR |
| 04/12/2001 | WO2001025239A2 Oxazinoquinolones useful for the treatment of viral infections |
| 04/12/2001 | WO2001025238A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 04/12/2001 | WO2001025237A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | WO2001025233A1 Piperidine derivatives |
| 04/12/2001 | WO2001025228A1 Amine derivatives |
| 04/12/2001 | WO2001025220A1 Triazine kinase inhibitors |
| 04/12/2001 | WO2001025217A1 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 04/12/2001 | WO2001025210A2 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands |
| 04/12/2001 | WO2001025209A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |